A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1 b

Journal of Immunology

Volumn 188, Issue 1, 2012, Pages 302-310

  Zeng, Li ^a   Sullivan, Lucy C ^b   Vivian, Julian P ^a   Walpole, Nicholas G ^a   Harpur, Christopher M ^b   Rossjohn, Jamie ^a   Clements, Craig S ^a   Brooks, Andrew G ^b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; HLA B ANTIGEN; HLA E ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2A; PEPTIDE; QA 1B; QDM PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CRYSTAL STRUCTURE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; STRUCTURAL HOMOLOGY; STRUCTURE ANALYSIS;

ANIMALS; ANTIGEN PRESENTATION; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MICE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; PEPTIDES; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; SPECIES SPECIFICITY; STRUCTURAL HOMOLOGY, PROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84855416384     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102379     Document Type: Article

References (64)

1. Falk, K., O. Rötzschke, S. Stevanović, G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351: 290-296. (Pubitemid 21896578)
2. MacDonald, W. A., A. W. Purcell, N. A. Mifsud, L. K. Ely, D. S. Williams, L. Chang, J. J. Gorman, C. S. Clements, L. Kjer-Nielsen, D. M. Koelle, et al. 2003. A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J. Exp. Med. 198: 679-691. (Pubitemid 37087768)
3. Kjer-Nielsen, L., C. S. Clements, A. G. Brooks, A. W. Purcell, M. R. Fontes, J. McCluskey, and J. Rossjohn. 2002. The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization. J. Immunol. 169: 5153-5160. (Pubitemid 35217185)
4. Reid, S.W., S.McAdam, K. J. Smith, P. Klenerman, C. A. O'Callaghan, K. Harlos, B. K. Jakobsen, A. J. McMichael, J. I. Bell, D. I. Stuart, and E. Y. Jones. 1996. Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J. Exp. Med. 184: 2279-2286. (Pubitemid 27023728)
5. Sette, A., and J. Sidney. 1998. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr. Opin. Immunol. 10: 478-482. (Pubitemid 28393833)
6. Rodgers, J. R., and R. G. Cook. 2005. MHC class Ib molecules bridge innate and acquired immunity. Nat. Rev. Immunol. 5: 459-471. (Pubitemid 40835034)
7. Sullivan, L. C., H. L. Hoare, J. McCluskey, J. Rossjohn, and A. G. Brooks. 2006. A structural perspective on MHC class Ib molecules in adaptive immunity. Trends Immunol. 27: 413-420. (Pubitemid 44216194)
8. Shawar, S. M., R. G. Cook, J. R. Rodgers, and R. R. Rich. 1990. Specialized functions of MHC class I molecules. I. An N-formyl peptide receptor is required for construction of the class I antigen Mta. J. Exp. Med. 171: 897-912. (Pubitemid 20088990)
9. Clements, C. S., L. Kjer-Nielsen, L. Kostenko, H. L. Hoare, M. A. Dunstone, E. Moses, K. Freed, A. G. Brooks, J. Rossjohn, and J. McCluskey. 2005. Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface. Proc. Natl. Acad. Sci. USA 102: 3360-3365. (Pubitemid 40328050)
10. Hoare, H. L., L. C. Sullivan, C. S. Clements, L. K. Ely, T. Beddoe, K. N. Henderson, J. Lin, H. H. Reid, A. G. Brooks, and J. Rossjohn. 2008. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors. J. Mol. Biol. 377: 1297-1303.
11. O'Callaghan, C. A., J. Tormo, B. E. Willcox, V. M. Braud, B. K. Jakobsen, D. I. Stuart, A. J. McMichael, J. I. Bell, and E. Y. Jones. 1998. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol. Cell 1: 531-541. (Pubitemid 128374689)
12. Walpole, N. G., L. Kjer-Nielsen, L. Kostenko, J. McCluskey, A. G. Brooks, J. Rossjohn, and C. S. Clements. 2010. The structure and stability of the monomorphic HLA-G are influenced by the nature of the bound peptide. J. Mol. Biol. 397: 467-480.
13. Clements, C. S., L. Kjer-Nielsen, J. McCluskey, and J. Rossjohn. 2007. Structural studies on HLA-G: implications for ligand and receptor binding. Hum. Immunol. 68: 220-226. (Pubitemid 46497514)
14. Hofstetter, A. R., L. C. Sullivan, A. E. Lukacher, and A. G. Brooks. 2011. Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunity. Curr. Opin. Immunol. 23: 104-110.
15. Rajagopalan, S., and E. O. Long. 1999. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med. 189: 1093-1100.
16. Shiroishi, M., K. Tsumoto, K. Amano, Y. Shirakihara, M. Colonna, V. M. Braud, D. S. Allan, A. Makadzange, S. Rowland-Jones, B. Willcox, et al. 2003. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA 100: 8856-8861. (Pubitemid 36899188)
17. Borrego, F., M. Ulbrecht, E. H. Weiss, J. E. Coligan, and A. G. Brooks. 1998. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187: 813-818. (Pubitemid 28115198)
18. Braud, V. M., D. S. Allan, C. A. O'Callaghan, K. Söderström, A. D'Andrea, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795-799. (Pubitemid 28099678)
19. Petrie, E. J., C. S. Clements, J. Lin, L. C. Sullivan, D. Johnson, T. Huyton, A. Heroux, H. L. Hoare, T. Beddoe, H. H. Reid, et al. 2008. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J. Exp. Med. 205: 725-735. (Pubitemid 351439316)
20. Sullivan, L. C., C. S. Clements, T. Beddoe, D. Johnson, H. L. Hoare, J. Lin, T. Huyton, E. J. Hopkins, H. H. Reid, M. C. Wilce, et al. 2007. The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition. Immunity 27: 900-911. (Pubitemid 50013980)
21. Joosten, S. A., K. E. van Meijgaarden, P. C. van Weeren, F. Kazi, A. Geluk, N. D. Savage, J. W. Drijfhout, D. R. Flower, W. A. Hanekom, M. R. Klein, and T. H. Ottenhoff. 2010. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity. PLoS Pathog. 6: e1000782.
22. Pietra, G., C. Romagnani, P. Mazzarino, M. Falco, E. Millo, A. Moretta, L. Moretta, and M. C. Mingari. 2003. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. Proc. Natl. Acad. Sci. USA 100: 10896-10901. (Pubitemid 37140124)
23. Aldrich, C. J., J. R. Rodgers, and R. R. Rich. 1988. Regulation of Qa-1 expression and determinant modification by an H-2D-linked gene, Qdm. Immunogenetics 28: 334-344.
24. Aldrich, C. J., R. Waltrip, E. Hermel, M. Attaya, K. F. Lindahl, J. J. Monaco, and J. Forman. 1992. T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter. J. Immunol. 149: 3773-3777. (Pubitemid 23068854)
25. Lowen, L. C., C. J. Aldrich, and J. Forman. 1993. Analysis of T cell receptors specific for recognition of class IB antigens. J. Immunol. 151: 6155-6165. (Pubitemid 23340361)
26. Vidović, D., M. Roglić, K. McKune, S. Guerder, C. MacKay, and Z. Dembić. 1989. Qa-1 restricted recognition of foreign antigen by a gamma delta T-cell hybridoma. Nature 340: 646-650. (Pubitemid 19202575)
27. Aldrich, C. J., A. DeCloux, A. S. Woods, R. J. Cotter, M. J. Soloski, and J. Forman. 1994. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell 79: 649-658. (Pubitemid 24363808)
28. DeCloux, A., A. S. Woods, R. J. Cotter, M. J. Soloski, and J. Forman. 1997. Dominance of a single peptide bound to the class I(B) molecule, Qa-1b. J. Immunol. 158: 2183-2191. (Pubitemid 127470001)
29. Vance, R. E., J. R. Kraft, J. D. Altman, P. E. Jensen, and D. H. Raulet. 1998. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 188: 1841-1848. (Pubitemid 28536771)
30. Vance, R. E., A. M. Jamieson, and D. H. Raulet. 1999. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J. Exp. Med. 190: 1801-1812. (Pubitemid 30013846)
31. Yeager, M., S. Kumar, and A. L. Hughes. 1997. Sequence convergence in the peptide-binding region of primate and rodent MHC class Ib molecules. Mol. Biol. Evol. 14: 1035-1041. (Pubitemid 27419239)
32. Joly, E., and V. Rouillon. 2006. The orthology of HLA-E and H2-Qa1 is hidden by their concerted evolution with other MHC class I molecules. Biol. Direct 1: 2.
33. Clements, C. S., L. Kjer-Nielsen, W. A. MacDonald, A. G. Brooks, A.W. Purcell, J. McCluskey, and J. Rossjohn. 2002. The production, purification and crystallization of a soluble heterodimeric form of a highly selected T-cell receptor in its unliganded and liganded state. Acta Crystallogr. D Biol. Crystallogr. 58: 2131-2134. (Pubitemid 35450840)
34. Hoare, H. L., L. C. Sullivan, G. Pietra, C. S. Clements, E. J. Lee, L. K. Ely, T. Beddoe, M. Falco, L. Kjer-Nielsen, H. H. Reid, et al. 2006. Structural basis for a major histocompatibility complex class Ib-restricted T cell response. Nat. Immunol. 7: 256-264.
35. Otwinowski, Z. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276: 307-326. (Pubitemid 27085611)
36. McCoy, A. J. 2007. Solving structures of protein complexes by molecular replacement with Phaser. Acta Crystallogr. D Biol. Crystallogr. 63: 32-41.
37. Collaborative Computational Project, Number 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50: 760-763.
38. Adams, P. D., R. W. Grosse-Kunstleve, L. W. Hung, T. R. Ioerger, A. J. McCoy, N. W. Moriarty, R. J. Read, J. C. Sacchettini, N. K. Sauter, and T. C. Terwilliger. 2002. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58: 1948-1954. (Pubitemid 35337293)
39. Emsley, P., and K. Cowtan. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60: 2126-2132. (Pubitemid 41742764)
40. Davis, I. W., A. Leaver-Fay, V. B. Chen, J. N. Block, G. J. Kapral, X. Wang, L. W. Murray, W. B. Arendall, III, J. Snoeyink, J. S. Richardson, and D. C. Richardson. 2007. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35(Web Server issue): W375-383.
41. Lovell, S. C., I. W. Davis, W. B. Arendall, III, P. I. de Bakker, J. M. Word, M. G. Prisant, J. S. Richardson, and D. C. Richardson. 2003. Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins 50: 437-450. (Pubitemid 36158457)
42. Brooks, A. G., F.Borrego, P. E. Posch, A. Patamawenu, C. J. Scorzelli, M. Ulbrecht, E. H. Weiss, and J. E. Coligan. 1999. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. J. Immunol. 162: 305-313. (Pubitemid 29018934)
43. Kaiser, B. K., F. Barahmand-Pour, W. Paulsene, S. Medley, D. E. Geraghty, and R. K. Strong. 2005. Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics. J. Immunol. 174: 2878-2884. (Pubitemid 40279705)
44. Fremont, D. H., E. A. Stura, M. Matsumura, P. A. Peterson, and I. A. Wilson. 1995. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc. Natl. Acad. Sci. USA 92: 2479-2483.
45. Turner, S. J., K. Kedzierska, H. Komodromou, N. L. La Gruta, M. A. Dunstone, A. I. Webb, R. Webby, H. Walden, W. Xie, J. McCluskey, et al. 2005. Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations. Nat. Immunol. 6: 382-389. (Pubitemid 41716778)
46. He, X., P. Tabaczewski, J. Ho, I. Stroynowski, and K. C. Garcia. 2001. Promiscuous antigen presentation by the nonclassical MHC Ib Qa-2 is enabled by a shallow, hydrophobic groove and self-stabilized peptide conformation. Structure 9: 1213-1224. (Pubitemid 34025055)
47. Wang, C. R., A. R. Castaño, P. A. Peterson, C. Slaughter, K. F. Lindahl, and J. Deisenhofer. 1995. Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3. Cell 82: 655-664.
48. Madden, D. R., D. N. Garboczi, and D. C. Wiley. 1993. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75: 693-708. (Pubitemid 23346368)
49. Kurepa, Z., and J. Forman. 1997. Peptide binding to the class Ib molecule, Qa-1b. J. Immunol. 158: 3244-3251. (Pubitemid 127484040)
50. Theodossis, A., C. Guillonneau, A. Welland, L. K. Ely, C. S. Clements, N. A. Williamson, A. I. Webb, J. A. Wilce, R. J. Mulder, M. A. Dunstone, et al. 2010. Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition. Proc. Natl. Acad. Sci. USA 107: 5534-5539.
51. Kurepa, Z., C. A. Hasemann, and J. Forman. 1998. Qa-1b binds conserved class I leader peptides derived from several mammalian species. J. Exp. Med. 188: 973-978. (Pubitemid 28433423)
52. Strong, R. K., M. A. Holmes, P. Li, L. Braun, N. Lee, and D. E. Geraghty. 2003. HLA-E allelic variants: correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J. Biol. Chem. 278: 5082-5090. (Pubitemid 36801018)
53. Wada, H., N. Matsumoto, K. Maenaka, K. Suzuki, and K. Yamamoto. 2004. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues. Eur. J. Immunol. 34: 81-90. (Pubitemid 38111523)
54. Llano, M., N. Lee, F. Navarro, P. García, J. P. Albar, D. E. Geraghty, and M. López-Botet. 1998. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur. J. Immunol. 28: 2854-2863. (Pubitemid 28425243)
55. Lu, L., K. Ikizawa, D. Hu, M. B. Werneck, K. W. Wucherpfennig, and H. Cantor. 2007. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 26: 593-604. (Pubitemid 46756350)
56. Oliveira, C. C., P. A. van Veelen, B. Querido, A. de Ru, M. Sluijter, S. Laban, J. W. Drijfhout, S. H. van der Burg, R. Offringa, and T. van Hall. 2010. The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects. [Published erratum appears in 2010 J. Exp. Med. 207: 671.] J. Exp. Med. 207: 207-221.
57. Kraft, J. R., R. E. Vance, J. Pohl, A. M. Martin, D. H. Raulet, and P. E. Jensen. 2000. Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. J. Exp. Med. 192: 613-624.
58. Lo, W. F., A. S. Woods, A. DeCloux, R. J. Cotter, E. S. Metcalf, and M. J. Soloski. 2000. Molecular mimicry mediated by MHC class Ib molecules after infection with Gram-negative pathogens. Nat. Med. 6: 215-218.
59. Chun, T., C. J. Aldrich, M. E. Baldeón, L. V. Kawczynski, M. J. Soloski, and H. R. Gaskins. 1998. Constitutive and regulated expression of the class IB molecule Qa-1 in pancreatic beta cells. Immunology 94: 64-71. (Pubitemid 28412789)
60. Fiorillo, M. T., C. Rückert, M. Hülsmeyer, R. Sorrentino, W. Saenger, A. Ziegler, and B. Uchanska-Ziegler. 2005. Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes. J. Biol. Chem. 280: 2962-2971. (Pubitemid 40189406)
61. MacDonald, W. A., Z. Chen, S. Gras, J. K. Archbold, F. E. Tynan, C. S. Clements, M. Bharadwaj, L. Kjer-Nielsen, P. M. Saunders, M. C. Wilce, et al. 2009. T cell allorecognition via molecular mimicry. Immunity 31: 897-908.
62. Tynan, F. E., S. R. Burrows, A. M. Buckle, C. S. Clements, N. A. Borg, J. J. Miles, T. Beddoe, J. C. Whisstock, M. C. Wilce, S. L. Silins, et al. 2005. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat. Immunol. 6: 1114-1122. (Pubitemid 41541789)
63. Archbold, J. K., W. A. MacDonald, S. Gras, L. K. Ely, J. J. Miles, M. J. Bell, R. M. Brennan, T. Beddoe, M. C. Wilce, C. S. Clements, et al. 2009. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition. J. Exp. Med. 206: 209-219.
64. Miller, J. D., D. A. Weber, C. Ibegbu, J. Pohl, J. D. Altman, and P. E. Jensen. 2003. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2. J. Immunol. 171: 1369-1375. (Pubitemid 36900069)